Study of a heart pump for high-risk angioplasty
Part of Heart & circulation clinical trials.
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are stable and scheduled for a planned or urgent (not emergency) high-risk angioplasty
- Your heart team has decided you need extra support during the procedure
- You have not had a stroke in the last 6 months or any stroke with lasting nerve damage
- You do not have a blood clot in the main pumping chamber of your heart
- You are not on dialysis for kidney failure
- You are not pregnant or planning to become pregnant within 90 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at using a temporary heart pump called Impella ECP during planned high-risk heart stent procedures (PCI). It may help doctors support the heart more safely while placing the stents.
This trial tests whether a small heart-support device called Impella CP helps protect your heart during complex coronary angioplasty (a procedure to open blocked heart arteries). You may qualify if you have weak heart function and specific patterns of blocked arteries that make the procedure higher risk.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This trial tests the iVAC 2L device, a temporary heart pump placed in the main artery, to help patients who need a high-risk angioplasty (PCI) because of a very narrowed or blocked coronary artery. The goal is to prevent the heart from failing during the procedure.
This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.
This trial tests a device called Ventiflow LP that supports the heart during high-risk stent placement (PCI) in people whose hearts are weak or have complex blockages. It may be an option if surgery is too risky or you prefer not to have it.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.